In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

Routine brain scans are starting to reveal something that was invisible to doctors a decade ago: subtle structural changes ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new ...

Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in understanding of brain health ...

New research shows that deep learning can use EEG signals to distinguish Alzheimer’s disease from frontotemporal dementia ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in ...

Artificial intelligence is moving from the lab into the clinic, and one of its most provocative promises is that it might ...

The researchers assessed the association between Alzheimer’s biomarkers and body mass index (BMI), according to a press ...